Over time, flow cytometry has gained considerable attention as an analytical method in disease diagnosis and drug development; however, it is associated with some challenges that has prompted stakeholders to outsource flow cytometry related operations
Roots Analysis has announced the addition of Flow Cytometry Services Market, 2022-2035 report to its list of offerings.
Given the growing healthcare burden related to cancer and immunological disease conditions, and developments in immunological and biomedical research, the adoption of flow cytometry in diagnostic, R&D and clinical development processes, is expected to increase, which in turn will increase dependency on flow cytometry services providers to optimize process costs, overcome complexities associated with the process and improve process timelines.
To order this 100+ pages report, which features 30+ figures and 30+ tables, please visit this link
Presently, 30 players based in different regions across the globe claim to offer flow cytometry services
Majority of the flow cytometry service providers are mid-sized players (51-500 employees, 40%), followed by small players (11-50 employees, 33%) and large organizations (1,000+ employees, 27%). Additionally, most of the service providers (~75%) are based in North America, followed by those having headquarters in Europe and Asia-Pacific regions.
Over 70% of the companies claim to offer analytical flow cytometry related services
Majority of the providers (80%) claim to offer analytical flow cytometric services based on cell profiling and subsetting. This is followed by players (67%) that claim to provide analytical services based on PBMC analysis and whole blood cell analysis (50%), respectively.
Partnership activity within this domain has increased at a CAGR of 37%, between 2010 and 2021
Majority of the agreements were inked in 2020 (20%). It is worth mentioning that most of the partnerships inked in this domain were instances of acquisitions / mergers (48%), followed by distribution / supply agreements (17%) and platform utilization / integration agreements (17%).
North America and Europe are anticipated to capture close to 85% share in the market in 2035
Owing to increased investment in immunological and biomedical research and initiatives for utilization of flow cytometry as a diagnostic technique for cancers and immunological disorders, the market is likely to grow at a pace of (9.73%) in the long term. Moreover, Asia-Pacific is likely to grow at a faster pace.
To request a sample copy / brochure of this report, please visit this link
The financial opportunity within the flow cytometry services market has been analyzed across the following segments:
The research includes profiles of key players (listed below); each profile features a brief overview of the company, recent developments (including partnerships and collaborations) and an informed future outlook.
For additional details, please visit https://www.rootsanalysis.com/reports/flow-cytometry-services-market.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
MEDIA CITATIONS
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES
.png)
